| |
| |
|
| Insider
Information: |
Thomas John C |
| Relationship: |
|
| City: |
Destin |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
2,145,625 |
|
|
Indirect Shares
|
3,822,800 |
|
|
| Direct
Value |
$14,043,636 |
|
|
|
Indirect Value
|
$25,066,272 |
|
|
| Total
Shares |
5,968,425 |
|
|
| Total
Value |
$39,109,907 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
3.0
|
| Percentage
Gain/Loss : |
 -92.5%
|
 210.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mimedx Group Inc |
MDXG |
Officer |
2008-02-08 |
1,774,188 |
2008-02-08 |
3,493,304 |
Premium* |
|
|
Point Therapeutics Inc |
POTP |
Director |
2012-02-02 |
10,000 |
2008-02-12 |
315,610 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
Director |
2015-06-29 |
37,000 |
2014-12-15 |
0 |
Premium* |
|
|
Medovex Corp. |
MDVX |
Director |
2017-12-15 |
115,960 |
|
0 |
Premium* |
|
|
ImmunityBio, Inc |
IBRX |
Director |
2020-12-10 |
207,477 |
2020-12-10 |
13,886 |
Premium* |
|
|
Virios Therapeutics, Llc |
VIRI |
|
2022-01-04 |
1,000 |
2022-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2014-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2015-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
12,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2015-06-29 |
4 |
OE |
$3.30 |
$87,125 |
D/D |
25,000 |
37,000 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2016-05-26 |
4 |
OE |
$0.22 |
$60,016 |
D/D |
277,725 |
335,789 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2016-11-22 |
4 |
S |
$7.50 |
$97,500 |
D/D |
(13,000) |
322,789 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2016-11-23 |
4/A |
S |
$7.50 |
$57,893 |
D/D |
(7,719) |
315,070 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2016-11-23 |
4 |
S |
$7.50 |
$52,500 |
D/D |
(7,000) |
315,789 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2016-11-25 |
4 |
S |
$7.50 |
$46,260 |
D/D |
(6,168) |
309,621 |
0 |
- |
|
| MDVX |
Medovex Corp. |
Director |
– • – |
2017-12-15 |
4 |
S |
$0.70 |
$4,200 |
D/D |
(6,000) |
115,960 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2019-09-05 |
4 |
S |
$1.25 |
$3,705 |
D/D |
(2,964) |
391,105 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2019-09-06 |
4 |
S |
$1.24 |
$8,779 |
D/D |
(7,080) |
384,025 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2019-09-09 |
4 |
S |
$1.24 |
$17,305 |
D/D |
(13,956) |
370,069 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2020-08-11 |
4 |
S |
$10.35 |
$207,042 |
D/D |
(20,000) |
310,069 |
0 |
% |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2020-08-13 |
4 |
S |
$9.34 |
$376,600 |
D/D |
(40,000) |
270,069 |
0 |
% |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2020-08-19 |
4 |
S |
$9.19 |
$183,800 |
D/D |
(20,000) |
250,069 |
0 |
% |
|
40 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
